Nada Ibrahim-Nasser
Research Subjects
Nada Ibrahim-Nasser has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Elise Champeaux-Orange
Radiotherapy and Oncology Department, CHU Orleans, Orleans, France
1 shared publication - Emneh Hammoud
EA 4708 I3MTO Laboratory, University Orleans, 45067, Orleans, France
1 shared publication - Eric Lespessailles
Translational Medicine Research Platform, PRIMMO, University Hospital Center of Orleans, 14 Avenue de l’Hôpital, 45100 Orleans, France
1 shared publication - Gilles Metrard
Nuclear Medicine Department, Orléans University Hospital, Orléans, France
1 shared publication - Hechmi Toumi
Translational Medicine Research Platform, PRIMMO, University Hospital Center of Orleans, 14 Avenue de l’Hôpital, 45100 Orleans, France
1 shared publication - Matthieu Bailly
Affiliations Nuclear Medicine Department, CHU ORLEANS, Orleans, France, LI2RSO, Orleans University, Orleans, France
1 shared publication
Latest Publications
- Open Access
- 24 November 2023
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 49 (1) , 74-75
Osteonecrosis of the Femoral Head as a Potential Pitfall in 18F-PSMA-1007 PET
PSMA-targeted PET agents are mainly involved for prostate cancer; however, unspecific bone uptakes can be challenging for the clinician. We report the case of a 71-year-old man with history of recurrent prostate cancer initially treated by surgery and radiation therapy. 18F-PSMA 1007 PET/CT was performed. Beside hyperfixing lymph nodes, focal uptake was found in right femoral head with shell subchondral hypofixation and no morphologic correlate on CT. MRI found bilateral osteonecrosis of the femoral head. This case emphasizes that osteonecrosis of the femoral head can mimic a metastasis uptake, even with normal CT, without however the fixation being constant.
- 24 November 2023
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 49 (1) , 74-75
Open AccessOsteonecrosis of the Femoral Head as a Potential Pitfall in 18F-PSMA-1007 PET
PSMA-targeted PET agents are mainly involved for prostate cancer; however, unspecific bone uptakes can be challenging for the clinician. We report the case of a 71-year-old man with history of recurrent prostate cancer initially treated by surgery and radiation therapy. 18F-PSMA 1007 PET/CT was performed. Beside hyperfixing lymph nodes, focal uptake was found in right femoral head with shell subchondral hypofixation and no morphologic correlate on CT. MRI found bilateral osteonecrosis of the femoral head. This case emphasizes that osteonecrosis of the femoral head can mimic a metastasis uptake, even with normal CT, without however the fixation being constant.
- Open Access
- 28 March 2019
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 21 (1) , 1-8
Consequences of bariatric surgery on outcomes in rheumatic diseases
Obesity is associated with numerous comorbidities including some rheumatic conditions. Through adipose-derived inflammation, obesity has been shown to induce increased initiation, progression, and worse responses on outcomes of rheumatic diseases. Bariatric surgery is being increasingly used thanks to its positive effects on major comorbidities such as type 2 diabetes mellitus and hypertension. Consequently, surgically induced weight and adipose tissue losses might play a role in the course of rheumatic conditions. The present narrative literature review aims to provide rheumatologists with an update on both the positive and negative effects of bariatric surgery on the rheumatic outcomes reported in the literature. Current evidence seems to show improved outcomes in obese populations with rheumatic disorders after bariatric surgery. However, rigorous prospective controlled studies with long follow-up are needed. Bariatric procedures have deleterious effects on bone and are associated with an increased risk of fractures.
- 28 March 2019
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 21 (1) , 1-8
Open AccessConsequences of bariatric surgery on outcomes in rheumatic diseases
Obesity is associated with numerous comorbidities including some rheumatic conditions. Through adipose-derived inflammation, obesity has been shown to induce increased initiation, progression, and worse responses on outcomes of rheumatic diseases. Bariatric surgery is being increasingly used thanks to its positive effects on major comorbidities such as type 2 diabetes mellitus and hypertension. Consequently, surgically induced weight and adipose tissue losses might play a role in the course of rheumatic conditions. The present narrative literature review aims to provide rheumatologists with an update on both the positive and negative effects of bariatric surgery on the rheumatic outcomes reported in the literature. Current evidence seems to show improved outcomes in obese populations with rheumatic disorders after bariatric surgery. However, rigorous prospective controlled studies with long follow-up are needed. Bariatric procedures have deleterious effects on bone and are associated with an increased risk of fractures.